This book includes a plain text version that is designed for high accessibility. To use this version please follow this link.
12-01 :: January 2012


nanotimes


Companies Facts


mer – you or me.” nanoRETE is backed by Michigan Accelerator Fund I, a Grand Rapids, Mich., USA, investment partnership focused on Michigan-based early stage life science and technology companies.


panel, is currently under FDA review. Recently, Nanosphere obtained CE-IVD Mark for regulatory approval of the full BC-GP test as an in vitro dia- gnostic in Europe.


In a single automated test, the Verigene BC-S test provides detection of Staphylococcus aureus, Staphy- lococcus epidermidis, and the mecA gene.


http://www.nanosphere.us N


Biosensor chips for use in handheld devices for detecting biohazards in the field, developed by biosystems and agri- cultural engineering professor Evangelyn Alocilja. © Kurt Stepnitz / nanoRETE


http://www.nanorete.com N gene®


anosphere, Inc. (NASDAQ: NSPH) has received 510(k) clearance from the FDA for the Veri- Staphylococcus Blood Culture Nucleic Acid


Test (BC-S). The BC-S test expands Nanosphere‘s in- fectious disease test capabilities to include the rapid detection of bacteria that cause deadly bloodstream infections. The Verigene BC-S test was submitted to the FDA as the first phase of a stepwise process to obtain clearance for a larger test panel which will be marketed as the Verigene BC-GP test. The test will be comprised of up to 16 bacterial/resistance marker targets, all on a single test cartridge. A second 510(k), needed to obtain clearance for the full BC-GP test


anostart AG (OTCQX: NASRY) has acquired two shares in its equity investment Holmenkol AG


from co-shareholder Nanogate (N7G.FSE). It now holds 50% plus one share, giving it a majority stake in Holmenkol. The transaction was approved at the Annual General Meeting of Holmenkol on December 9, 2011, and has now been carried out. Marco Beck- mann, CEO of Nanostart, commented: “Nanostart has always been convinced of the capabilities of Hol- menkol, which is why we acted quickly to exercise our preemption right.”


http://www.nanostart.de N


aturalNano (OTCBB: NNAN.OB) and Sparta Armor have entered into an exclusive Joint


Development and Supply Agreement to utilize their combined technologies. NaturalNano and Sparta Armor will develop a range of products and applica-


tions that combine their respective patented technologies to create a new class of high perfor- mance additives. These will significantly improve the mechanical properties of Sparta‘s Vehicle and Body Armor materials. Under the agreement,


33


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97